SU843751A3 - Способ получени производных бензимидазола - Google Patents

Способ получени производных бензимидазола Download PDF

Info

Publication number
SU843751A3
SU843751A3 SU772552626A SU2552626A SU843751A3 SU 843751 A3 SU843751 A3 SU 843751A3 SU 772552626 A SU772552626 A SU 772552626A SU 2552626 A SU2552626 A SU 2552626A SU 843751 A3 SU843751 A3 SU 843751A3
Authority
SU
USSR - Soviet Union
Prior art keywords
carbon atoms
substituents
halogen
alkyl
mixture
Prior art date
Application number
SU772552626A
Other languages
English (en)
Russian (ru)
Inventor
Деннет Миллз Стюарт
Original Assignee
Империал Кемикал Индас Триз Лимитед (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51426/76A external-priority patent/GB1585965A/en
Application filed by Империал Кемикал Индас Триз Лимитед (Фирма) filed Critical Империал Кемикал Индас Триз Лимитед (Фирма)
Application granted granted Critical
Publication of SU843751A3 publication Critical patent/SU843751A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SU772552626A 1976-12-09 1977-12-09 Способ получени производных бензимидазола SU843751A3 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB51426/76A GB1585965A (en) 1976-12-09 1976-12-09 3,4-dihydropyrimido (1,2 - )benzimidazol - 2(1h) - ones
GB3334177 1977-08-09

Publications (1)

Publication Number Publication Date
SU843751A3 true SU843751A3 (ru) 1981-06-30

Family

ID=26261828

Family Applications (1)

Application Number Title Priority Date Filing Date
SU772552626A SU843751A3 (ru) 1976-12-09 1977-12-09 Способ получени производных бензимидазола

Country Status (23)

Country Link
US (1) US4167569A (enExample)
JP (1) JPS5390296A (enExample)
AT (1) AT359068B (enExample)
AU (1) AU514427B2 (enExample)
CA (1) CA1086727A (enExample)
CH (1) CH633291A5 (enExample)
CS (1) CS199696B2 (enExample)
DD (1) DD133330A5 (enExample)
DE (1) DE2754930A1 (enExample)
ES (1) ES464862A1 (enExample)
FI (1) FI63577C (enExample)
FR (1) FR2373543A1 (enExample)
GR (1) GR65298B (enExample)
HU (1) HU176540B (enExample)
IE (1) IE45924B1 (enExample)
IL (1) IL53507A (enExample)
IT (1) IT1143729B (enExample)
NL (1) NL7713658A (enExample)
NO (1) NO774216L (enExample)
NZ (1) NZ185823A (enExample)
PL (1) PL107142B1 (enExample)
SE (1) SE435385B (enExample)
SU (1) SU843751A3 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
CA1157858A (en) 1979-12-03 1983-11-29 Ikuo Ueda Quinazoline derivatives
DE3208218A1 (de) * 1982-03-06 1983-09-08 Basf Ag, 6700 Ludwigshafen Isoindolinfarbstoffe und deren verwendung
RU2394824C1 (ru) * 2008-12-25 2010-07-20 Государственное научное учреждение Северо-Кавказский зональный научно-исследовательский ветеринарный институт Российской академии сельскохозяйственных наук ПРОИЗВОДНЫЕ ПИРИДО [1,2-a]БЕНЗИМИДАЗОЛА, ОБЛАДАЮЩИЕ АНТИБАКТЕРИАЛЬНЫМ ДЕЙСТВИЕМ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
AU2013283318B2 (en) 2012-06-27 2017-11-23 4Sc Ag Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468888A (en) * 1967-04-11 1969-09-23 Smithkline Corp 2-substituted pyrimido(1,2-a) benzimidazoles
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
US4072679A (en) * 1976-06-15 1978-02-07 E. R. Squibb & Sons, Inc. 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides

Also Published As

Publication number Publication date
DE2754930A1 (de) 1978-06-15
GR65298B (en) 1980-08-01
FI63577C (fi) 1983-07-11
CS199696B2 (en) 1980-07-31
CA1086727A (en) 1980-09-30
NO774216L (no) 1978-06-12
ES464862A1 (es) 1979-01-01
US4167569A (en) 1979-09-11
SE435385B (sv) 1984-09-24
FI773724A7 (fi) 1978-06-10
PL107142B1 (pl) 1980-01-31
HU176540B (en) 1981-03-28
IE45924L (en) 1978-06-09
ATA883677A (de) 1980-03-15
AU514427B2 (en) 1981-02-12
IE45924B1 (en) 1982-12-29
AT359068B (de) 1980-10-27
JPS5390296A (en) 1978-08-08
NZ185823A (en) 1980-08-26
FR2373543A1 (fr) 1978-07-07
CH633291A5 (de) 1982-11-30
PL202753A1 (pl) 1978-10-09
FI63577B (fi) 1983-03-31
FR2373543B1 (enExample) 1980-05-16
IT1143729B (it) 1986-10-22
NL7713658A (nl) 1978-06-13
SE7713958L (sv) 1978-06-10
IL53507A0 (en) 1978-03-10
AU3112177A (en) 1979-06-07
DD133330A5 (de) 1978-12-27
IL53507A (en) 1981-07-31

Similar Documents

Publication Publication Date Title
EP0642513B1 (de) Indolocarbazol-imide und deren verwendung
EP0362695A1 (de) Pyrrolocarbazol-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP0446141B1 (fr) Nouveaux dérivés d'imidazo [1,2-C] quinazoline leur procédé de préparation et les compositions pharmaceutiques les renfermant
PT89468B (pt) Processo para a preparacao de 6-fenil{di-hidro-3(2h)-piridazinonas substituidas e de composicoes farmaceuticas que as contem
SU843751A3 (ru) Способ получени производных бензимидазола
US5807851A (en) 2,3-Benzodiazepine Derivatives as non-competitive AMPA
RU2058982C1 (ru) 1-(3-хлорфенил)-4-оксиметил-7,8-диметокси-5н-2,3-бензо-диазепин или его терапевтически приемлемая соль присоединения кислоты
EP1472252A1 (en) Substituted fused pyrazolecarboxylic acid arylamides and related compounds
SU368752A1 (enExample)
Giraldi et al. Antiprotozoans. Synthesis and biological activity of some styrylimidazole derivatives
NZ236147A (en) Triazine derivatives, preparation and pharmaceutical compositions thereof.
CN117903049A (zh) 一种白藜芦醇衍生物及其制备方法和应用
Blood et al. Attempted Syntheses of Compounds Containing the 1, 6-Diazacyclodecapentaene Ring
US4372956A (en) 5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions containing them
Hester Jr Cyclodehydration Reactions of Tryptamine Derivatives with Acetone
SU1528319A3 (ru) Способ получени производных имидазола или их физиологически приемлемых солей
DD215545A5 (de) Verfahren zur herstellung eines (1,2,4)triazolo (4,3-a)chin-oxalin-4-amin-derivats
Sinitsyna et al. Synthesis of alkyl derivatives of 3, 7, 10-trioxo-2, 4, 6, 8, 9, 11-hexaaza [3.3. 3] propellane and evaluation of their biological activity
US4500708A (en) Benzothiazine derivatives
Lange et al. Bicyclic [b]‐heteroannulated pyridazine derivatives. 4. Cyclization reactions of 4‐aryltetrahydropyridazine‐3, 6‐dione 3‐hydrazones with some keto esters
GB1585965A (en) 3,4-dihydropyrimido (1,2 - )benzimidazol - 2(1h) - ones
SU805947A3 (ru) Способ получени производныхпиРиМидО /1,2-A/ бЕНзиМидАзОлА
SU1468902A1 (ru) Способ получени пирано @ 3,4-в @ индолов
SU1077571A3 (ru) Способ получени производных пиразоло-/1,5- @ /пиримидина
SU1424324A1 (ru) Способ получени 5-( @ -цианэтил)бензимидазо(2,1- @ )хиназолинонов-12 общей формулы 1